🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Anticoagulant Therapy

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC) NCT06401616Phase 46 sites📍 Copenhagen📍 Gentofte Municipality📍 Herning Odense University Hospital · Tests: OAC will be discontinued for the duration of the trial START-Register: Survey on Anticoagulated Patients Register NCT02219984n/a1 site📍 Bologna GUALTIERO PALARETI · Tests: Anticoagulants Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later NCT06644976n/a1 site📍 Kfar Saba Meir Hospital, Kfar Saba, Israel · Tests: femoral neck CRIF Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs NCT07309848n/a7 sites📍 Almelo📍 Amsterdam📍 Arnhem St. Antonius Hospital STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant NCT07007143Phase 41 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital · Tests: Experimental: Aspirin monotherapy, Active Comparator: Aspirin+Clopidogrel Intravenous Thrombolysis and NOAC NCT06749834Phase 32 sites📍 Hangzhou📍 Taizhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Intravenous thrombolysis Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department NCT06692504n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Vitamin K for Perioperative Warfarin Management NCT07515664Phase 41 site📍 Ann Arbor University of Michigan · Tests: Vitamin K, Warfarin (standard without loading), Warfarin (standard with loading) Personalized Anticoagulant Therapy for Pulmonary Thromboembolism NCT06341231n/a1 site📍 Changsha Xiangya Hospital of Central South University The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes. NCT05283174n/a1 site📍 Taipei National Taiwan University Hospital · Tests: Blood sampling to test drug level Phase I Study of MT1011 Injection in Healthy Subjects NCT07024160Phase 11 site📍 Beijing Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Tests: MT1011, Placebo Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture NCT07360899NA1 site📍 Kamenitz Institute of Cardiovascular Diseases, Vojvodina · Tests: LAA closure using the AtriLASH The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients NCT06998745NA1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Medication Therapy Management (MTM) model Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion NCT06949319n/a1 site📍 Esbjerg Nedim Tojaga Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study) NCT07372716NA1 site📍 Ottawa Ottawa Hospital Research Institute · Tests: standardized perioperative anticoagulation management Guideline Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia NCT05641142NA18 sites📍 Angers📍 Bordeaux📍 Boulogne-Billancourt University Hospital, Clermont-Ferrand · Tests: monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) NCT07469072Phase 21 site📍 Guangzhou Zhujiang Hospital · Tests: Nafamostat Low-Dose Group, Nafamostat High-Dose Group A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI) NCT07012629Phase 314 sites📍 Aalborg📍 Aarhus📍 Aarhus Aarhus University Hospital · Tests: acetylsalicyclic acid (ASA), Clopidogrel, Rosuvastatin, Atorvastatin Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake NCT06571149Phase 4109 sites📍 Eisenstadt📍 Graz📍 Innsbruck Insel Gruppe AG, University Hospital Bern · Tests: Tenecteplase or Alteplase PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years NCT05387954Phase 342 sites📍 Amiens📍 Bayonne📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Transcatheter PFO closure, Oral Anticoagulant, Direct-Acting, Antiplatelet therapy Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy NCT07796217Phase 41 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: Aspirin and low-dose rivaroxaban, Clopidogrel with or without aspirin NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI NCT05638867Phase 41 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Aspirin + Clopidogrel + Rivaroxaban, Aspirin + Clopidogrel Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT NCT06714734n/a2 sites📍 Bologna📍 Reggio Emilia IRCCS Azienda Ospedaliero-Universitaria di Bologna Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis NCT04660747n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Oral anticoagulant Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients NCT06487052NA1 site📍 Saint Petersburg Federal State Budgetary Institution, V. A. Almazov Federal … · Tests: Standard Catheter-Directed Low Dose Thrombolysis, Standard Anticoagulation Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets NCT05627375Phase 328 sites📍 Amiens📍 Angers📍 Besançon Centre Hospitalier Universitaire de Saint Etienne · Tests: Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP) Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy NCT07713537n/a2 sites📍 Barcelona📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: DOAC Level Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial NCT07454707Phase 31 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Edoxaban 15 mg, Aspirin or clopidogrel Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC NCT06241677NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: alteplase or tenecteplase International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants NCT04262492n/a1 site📍 Nancy Stéphane Zuily · Tests: Rivaroxaban
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy